Alcon Earnings: Competitive Pressure and Areas of Demand Softness Can't Stop Momentum
Alcon delivered growth of 5% for revenue and 14% for adjusted earnings per share in constant currencies in its third quarter.
Alcon Inc ALC
Bulls Say, Bears Say
Bulls
Alcon is one of the leading visioncare companies in the world, with a record of successful product development, and it will continue to launch technically superior products that should lead to market outperformance.
Bears
A misstep in commercial execution for new product launches could hinder Alcon's market position and weigh down future growth rates across business units.
News
Alcon's Swiss Shares Slide After Sales Growth Disappoints
Innovation and Product Launch Momentum Drive Alcon’s Third-Quarter 2026 Growth
Alcon Acquires Neurotech and ENCELTO, the Only FDA-Approved Treatment for MacTel Type 2
Alcon Gets FDA Approval for Brytly Eye Drops
FDA Approves Alcon’s BRYTLY Redness Reliever Eye Drops for Up to 12 Hours of Whiter, Brighter-Looking Eyes
Introducing Systane® PRO PRESERVATIVE-FREE: Alcon’s Longest Lasting, Triple-Action Formula for up to 12 Hours of Dry Eye Symptom Relief
Alcon Launches UNITY M, a Premium Ophthalmic Microscope Delivering Precise Control
Alcon Prices EUR 500 Million Senior Notes Offering
Trading Information
- Previous Close Price
- $72.46
- Day Range
- $71.64–73.96
- 52-Week Range
- $61.84–87.64
- Bid/Ask
- $67.87 / $75.23
- Shares Outstanding
- 480.40M
- Market Cap
- $34.51B
- Volume/Avg
- 2M / 2M
Key Statistics
- Price/Earnings (Normalized)
- 38.45
- Price/Sales
- 3.20
- Dividend Yield (Trailing)
- 0.50%
- Dividend Yield (Forward)
- 0.50%
- Dividend Payment Schedule
- May
- Total Yield
- 3.06%
Company Profile
Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Stock Style Box
- Large Core
- Total Number of Employees
- 25,942
- Website
- https://www.alcon.com
Competitors
Valuation
Metric | ALC | COO | AFX |
|---|---|---|---|
Price/Earnings (Normalized) | 38.45 | 13.50 | 22.42 |
Price/Book Value | 1.59 | 1.42 | 1.42 |
Price/Sales | 3.20 | 2.88 | 1.38 |
Price/Cash Flow | 13.30 | 12.86 | 12.23 |
Price/Earnings
ALC
COO
AFX
Financial Strength
Metric | ALC | COO | AFX |
|---|---|---|---|
Quick Ratio | 1.39 | 0.51 | 1.40 |
Current Ratio | 2.50 | 1.22 | 2.34 |
Interest Coverage | 4.39 | 6.18 | 7.20 |
Quick Ratio
ALC
COO
AFX
Profitability
Metric | ALC | COO | AFX |
|---|---|---|---|
Return on Assets (Normalized) | 5.25% | 7.25% | — |
Return on Equity (Normalized) | 7.52% | 10.89% | — |
Return on Invested Capital (Normalized) | 6.49% | 9.02% | — |
Return on Assets
ALC
COO
AFX
Medical Instruments & Supplies Industry Comparables
1-Day Chart | Name | Price | Morningstar Rating for Stocks | Capital Allocation | Economic Moat | Market Cap |
|---|---|---|---|---|---|---|
| Intuitive Surgical Inc ISRG | LOCK|md$mmH&l | LOCK|#!$ | $152B | |||
| Becton Dickinson & Co BDX | LOCK|>C | LOCK|xg^& | $59B | |||
| Medline Inc Ordinary Shares - Class A MDLN | LOCK|#&JgWPz | LOCK|m$@> | $35B | |||
| ResMed Inc RMD | LOCK|%#gp?%PW | LOCK|<&Tv | $34B | |||
| West Pharmaceutical Services Inc WST | LOCK|&$hGr$Q! | LOCK|>l | $29B | |||
| Solventum Corp SOLV | LOCK|>%BHw?M | LOCK|kD | $15B | |||
| Baxter International Inc BAX | LOCK|V? | LOCK|mDL^! | $13B | |||
| The Cooper Companies Inc COO | LOCK|fXN@#n | LOCK|@p$Z | $12B | |||
| Align Technology Inc ALGN | LOCK|#jnf&?? | LOCK|XwW#H | $12B |
United States